News Earnings Gaudium IVF and Women Health Limited Schedules Board Meeting for Q3FY26 Results on March 18, 2026Gaudium IVF and Women Health Limited Schedules Board Meeting for Q3FY26 Results on March 18, 2026
Gaudium IVF and Women Health Limited has scheduled its board meeting for March 18, 2026, to approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The company has notified BSE and NSE under SEBI Regulation 29, while implementing trading window restrictions for designated persons from February 27, 2026, until 48 hours after results declaration. The announcement demonstrates the company's regulatory compliance as a recently listed healthcare entity in Indian capital markets.
*this image is generated using AI for illustrative purposes only.
Gaudium IVF and Women Health Limited has scheduled a board meeting on March 18, 2026, to consider its quarterly financial results, marking an important milestone for the recently listed healthcare company. The announcement comes as the company prepares to disclose its performance for the quarter and nine months ended December 31, 2025.
Board Meeting Details
The company has formally notified both BSE Limited and National Stock Exchange of India Limited about the upcoming board meeting through a communication dated March 12, 2026. The meeting has been convened under Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Meeting Details: | Information |
|---|---|
| Date: | Wednesday, March 18, 2026 |
| Purpose: | Consider Q3FY26 unaudited results |
| Period Covered: | Quarter and nine months ended December 31, 2025 |
| Results Type: | Standalone and Consolidated Financial Results |
| Additional Action: | Take on record Limited Review Report of Auditor |
Trading Window Restrictions
In compliance with insider trading regulations, Gaudium IVF has implemented trading window restrictions for designated persons and their immediate relatives. The trading window closure aligns with the company's recent listing milestone and upcoming results announcement.
| Trading Window Details: | Timeline |
|---|---|
| Closure Start Date: | Friday, February 27, 2026 |
| Closure End: | 48 hours after results declaration |
| Applicable To: | Designated persons and immediate relatives |
| Regulatory Framework: | SEBI Insider Trading Regulations, 2015 |
Regulatory Compliance
The company has emphasized its adherence to multiple regulatory frameworks in its communication to stock exchanges. The trading window closure follows the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, along with the company's internal codes for conduct and fair disclosure.
Naveen Kumar, Company Secretary and Compliance Officer with membership number A69788, has signed the official communication on behalf of the company. The document reflects Gaudium IVF's commitment to maintaining transparency and regulatory compliance as a newly listed entity in the Indian capital markets.
20
